In last trading session, Pacific Biosciences of California Inc. (NASDAQ:PACB) saw 6.35 million shares changing hands with its beta currently measuring 1.30. Company’s recent per share price level of $6.41 trading at $0.74 or 13.05% at ring of the bell on the day assigns it a market valuation of $1
Pacific Biosciences of California Inc. (NASDAQ:PACB) traded at $5.74 at close of the session on Monday, 10/10/22, made a downward move of -6.06% on its previous day’s price. Looking at the stock we see that its previous close was $6.11 and the beta (5Y monthly) reads 1.51 with the day’s
Pacific Biosciences of California Inc. (NASDAQ:PACB) went down by -11.06% from its latest closing price compared to the recent 1-year high of $31.10. The company’s stock price has collected 5.25% of gains in the last five trading sessions. The Wall Street Journal reported on 02/09/21 that SoftBank
In the last trading session, 2.42 million shares of the Pacific Biosciences of California Inc. (NASDAQ:PACB) were traded, and its beta was 1.16. Most recently the company’s share price was $20.90, and it changed around $0.44 or 2.15% from the last close, which brings the market valuation of the co
Marijuana stocks, specifically Canopy Growth Corp (NYSE:CGC) and Aurora Cannabis Inc (NASDAQ:ACB), look poised to benefit big-time if Germany legalizes pot in the near future.